New anemia drug under Real-World watch in japan
NCT ID NCT04899661
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 25 times
Summary
This study follows about 1,000 Japanese adults with renal anemia—a condition where the kidneys don't produce enough hormone to make red blood cells—who are taking the drug Molidustat. Researchers are monitoring side effects like blood clots, high blood pressure, and heart problems, and checking if the drug boosts red blood cell counts. Participants are observed for up to 2 years using routine medical records and check-ups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Many facilities
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.